{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:03:36Z","timestamp":1777658616065,"version":"3.51.4"},"reference-count":27,"publisher":"American Diabetes Association","issue":"6","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,6,1]]},"abstract":"<jats:p>The in vitro behavior of skin fibroblasts from patients with or without diabetic nephropathy is associated with diabetic nephropathy risk. Here we compared skin fibroblast gene expression profiles from two groups of type 1 diabetic patients: 20 with very fast (\u201cfast-track\u201d) versus 20 with very slow (\u201cslow-track\u201d) rates of development of diabetic nephropathy lesions. Gene expression profiles of skin fibroblasts grown in 25 mmol\/l glucose for 36 h were assessed by Affymetrix HG-U133A GeneChips to determine the proportion of genes in a given biological pathway that were directionally consistent in their group differences. Five pathways reached statistical significance. All had significantly greater proportions of genes with higher expression levels in the fast-track group. These pathways, the first four of which are closely related and have overlapping genes, included oxidative phosphorylation (P &amp;lt; 0.001), electron transport system complex III (P = 0.017), citrate cycle (P = 0.037), propanoate metabolism (P = 0.044), and transcription factors (P = 0.046). These results support the concept that oxidative phosphorylation and related upstream pathways may be important in the pathogenesis of diabetic nephropathy. Whether these findings reflect inherent genetic cellular characteristics, \u201ccell memory,\u201d or both requires further study.<\/jats:p>","DOI":"10.2337\/db05-1438","type":"journal-article","created":{"date-parts":[[2006,5,26]],"date-time":"2006-05-26T20:00:23Z","timestamp":1148673623000},"page":"1826-1831","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":39,"title":["Diabetic Nephropathy Is Associated With Gene Expression Levels of Oxidative Phosphorylation and Related Pathways"],"prefix":"10.2337","volume":"55","author":[{"given":"Chunmei","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngki","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Luiza","family":"Caramori","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason H.","family":"Moore","sequence":"additional","affiliation":[{"name":"Computational Genetics Laboratory, Department of Genetics, Dartmouth Medical School, Lebanon, New Hampshire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen S.","family":"Rich","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josyf C.","family":"Mychaleckyj","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mauer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031210160415600_R1","doi-asserted-by":"crossref","unstructured":"Betteridge DJ: What is oxidative stress?Metabolism 49 (2 Suppl. 1):3\u20138,2000","DOI":"10.1016\/S0026-0495(00)80077-3"},{"key":"2022031210160415600_R2","doi-asserted-by":"crossref","unstructured":"Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature\u2008414: 813\u2013820,2001","DOI":"10.1038\/414813a"},{"key":"2022031210160415600_R3","doi-asserted-by":"crossref","unstructured":"Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M: Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest\u2008108: 1341\u20131348,2001","DOI":"10.1172\/JCI11235"},{"key":"2022031210160415600_R4","doi-asserted-by":"crossref","unstructured":"Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature\u2008404: 787\u2013790,2000","DOI":"10.1038\/35008121"},{"key":"2022031210160415600_R5","doi-asserted-by":"crossref","unstructured":"Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Senokuchi T, Matsuo T, Matsumura T, Tokunaga H, Brownlee M, Araki E: Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes\u200852: 2570\u20132577,2003","DOI":"10.2337\/diabetes.52.10.2570"},{"key":"2022031210160415600_R6","doi-asserted-by":"crossref","unstructured":"Han HJ, Lee YJ, Park SH, Lee JH, Taub M: High glucose-induced oxidative stress inhibits Na+\/glucose cotransporter activity in renal proximal tubule cells. Am J Physiol Renal Physiol\u2008288: F988\u2013F996,2005","DOI":"10.1152\/ajprenal.00327.2004"},{"key":"2022031210160415600_R7","doi-asserted-by":"crossref","unstructured":"Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes\u200854: 1615\u20131625,2005","DOI":"10.2337\/diabetes.54.6.1615"},{"key":"2022031210160415600_R8","doi-asserted-by":"crossref","unstructured":"DeRubertis FR, Craven PA, Melhem MF, Salah EM: Attenuation of renal injury in db\/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes\u200853: 762\u2013768,2004","DOI":"10.2337\/diabetes.53.3.762"},{"key":"2022031210160415600_R9","doi-asserted-by":"crossref","unstructured":"Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, Viberti GC: Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes\u200849: 2170\u20132177,2000","DOI":"10.2337\/diabetes.49.12.2170"},{"key":"2022031210160415600_R10","doi-asserted-by":"crossref","unstructured":"Chiarelli F, Di Marzio D, Santilli F, Mohn A, Blasetti A, Cipollone F, Mezzetti A, Verrotti A: Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy. Diabetes Care\u200828: 1690\u20131697,2005","DOI":"10.2337\/diacare.28.7.1690"},{"key":"2022031210160415600_R11","doi-asserted-by":"crossref","unstructured":"Huang C, Kim Y, Caramori ML, Fish AJ, Rich SS, Miller ME, Russell GB, Mauer M: Cellular basis of diabetic nephropathy. II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes. Diabetes\u200851: 3577\u20133581,2002","DOI":"10.2337\/diabetes.51.12.3577"},{"key":"2022031210160415600_R12","doi-asserted-by":"crossref","unstructured":"Huang C, Kim Y, Caramori ML, Fish AJ, Rich SS, Miller ME, Russell GB, Mauer M: Cellular basis of diabetic nephropathy. III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in type 1 diabetic patients. Diabetologia\u200847: 1789\u20131794,2004","DOI":"10.1007\/s00125-004-1533-1"},{"key":"2022031210160415600_R13","doi-asserted-by":"crossref","unstructured":"Trevisan R, Li LK, Messent J, Tariq T, Earle K, Walker JD, Viberti G: Na+\/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes\u200841: 1239\u20131246,1992","DOI":"10.2337\/diab.41.10.1239"},{"key":"2022031210160415600_R14","doi-asserted-by":"crossref","unstructured":"Trevisan R, Fioretto P, Barbosa J, Mauer M: Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity. Kidney Int\u200855: 2383\u20132389,1999","DOI":"10.1046\/j.1523-1755.1999.00478.x"},{"key":"2022031210160415600_R15","doi-asserted-by":"crossref","unstructured":"Iori E, Marescotti MC, Vedovato M, Ceolotto G, Avogaro A, Tiengo A, Del Prato S, Trevisan R: In situ protein kinase C activity is increased in cultured fibroblasts from type 1 diabetic patients with nephropathy. Diabetologia\u200846: 524\u2013530,2003","DOI":"10.1007\/s00125-003-1061-4"},{"key":"2022031210160415600_R16","doi-asserted-by":"crossref","unstructured":"Podesta F, Meregalli G, Ghelardi R, Del Giudice R, Asnaghi V, Maestroni A, Zerbini G: Low Ca(2+) pump activity in diabetic nephropathy. Am J Kidney Dis\u200838: 465\u2013472,2001","DOI":"10.1053\/ajkd.2001.26825"},{"key":"2022031210160415600_R17","doi-asserted-by":"crossref","unstructured":"Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME, Russell G, Mauer M: Cellular basis of diabetic nephropathy. 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes\u200851: 506\u2013513,2002","DOI":"10.2337\/diabetes.51.2.506"},{"key":"2022031210160415600_R18","unstructured":"Affymetrix Microarray Suite User\u2019s Guide. Version 5.0. Santa Clara, CA, Affymetrix,2001, p. 412\u2013415"},{"key":"2022031210160415600_R19","doi-asserted-by":"crossref","unstructured":"Reif DM, Dudek SM, Schaffer CM, Wang J, Moore JH: Exploratory visual analysis of pharmacogenomic results. Pac Symb Biocomput 296\u2013307,2005","DOI":"10.1142\/9789812702456_0028"},{"key":"2022031210160415600_R20","doi-asserted-by":"crossref","unstructured":"Reif DM, Moore JH: Visual analysis of statistical results from microarray studies of human breast cancer. Oncol Rep 15 (Spec. no.):1043\u20131047,2006","DOI":"10.3892\/or.15.4.1043"},{"key":"2022031210160415600_R21","doi-asserted-by":"crossref","unstructured":"Korshunov SS, Skulachev VP, Starkov AA: High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett\u2008416: 15\u201318,1997","DOI":"10.1016\/S0014-5793(97)01159-9"},{"key":"2022031210160415600_R22","doi-asserted-by":"crossref","unstructured":"Roy S, Sala R, Cagliero E, Lorenzi M: Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci U S A\u200887: 404\u2013408,1990","DOI":"10.1073\/pnas.87.1.404"},{"key":"2022031210160415600_R23","doi-asserted-by":"crossref","unstructured":"Bergstrom G, Johansson I, Wickman A, Gan L, Thorup C: Brief losartan treatment in young spontaneously hypertensive rats abates long-term blood pressure elevation by effects on renal vascular structure. J Hypertens\u200820: 1413\u20131421,2002","DOI":"10.1097\/00004872-200207000-00029"},{"key":"2022031210160415600_R24","doi-asserted-by":"crossref","unstructured":"Nagai Y, Yao L, Kobori H, Miyata K, Ozawa Y, Miyatake A, Yukimura T, Shokoji T, Kimura S, Kiyomoto H, Kohno M, Abe Y, Nishiyama A: Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol\u200816: 703\u2013711,2005","DOI":"10.1681\/ASN.2004080649"},{"key":"2022031210160415600_R25","doi-asserted-by":"crossref","unstructured":"Soldner A, Spahn-Langguth H, Mutschler E: HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats. J Pharm Biomed Anal\u200816: 863\u2013873,1998","DOI":"10.1016\/S0731-7085(97)00128-3"},{"key":"2022031210160415600_R26","doi-asserted-by":"crossref","unstructured":"Lurbe A, Fioretto P, Mauer M, LaPointe MS, Batlle D: Growth phenotype of cultured skin fibroblasts from IDDM patients with and without nephropathy and overactivity of the Na+\/H+ antiporter. Kidney Int\u200850: 1684\u20131693,1996","DOI":"10.1038\/ki.1996.486"},{"key":"2022031210160415600_R27","doi-asserted-by":"crossref","unstructured":"Ng LL, Davies JE, Siczkowski M, Sweeney FP, Quinn PA, Krolewski B, Krolewski AS: Abnormal Na+\/H+ antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. J Clin Invest\u200893: 2750\u20132757,1994","DOI":"10.1172\/JCI117291"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/55\/6\/1826\/660821\/zdb00606001826.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/55\/6\/1826\/660821\/zdb00606001826.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T02:30:23Z","timestamp":1736389823000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/55\/6\/1826\/15572\/Diabetic-Nephropathy-Is-Associated-With-Gene"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,1]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db05-1438","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,1]]}}}